News
Shares of Amgen Inc. AMGN slipped 1.37% to $272.05 Thursday, on what proved to be an all-around positive trading session for ...
Wellness company Pharmavite, owners of the Nature Made brand, officially opened its 225,000-square-foot, $250 million plant ...
Once-daily roflumilast foam significantly improves scalp and body psoriasis in 8 weeks and was well-tolerated in adolescents ...
Two excellent options right now are Amgen (NASDAQ: AMGN) and Microsoft (NASDAQ: MSFT). Here's why these two income stocks are ...
During the Keck Graduate Institute commencement ceremony on May 17, 2025, Robert A. Bradway will receive an honorary Doctor of Philosophy in Applied Life Sciences degree in recognition of his ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Amgen’s Tepezza ...
Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...
The U.S. Food and Drug Administration (FDA) on Thursday announced an expedited plan to implement artificial intelligence (AI) ...
TScan Therapeutics, Inc.’s TCRX share price has surged by 5.15%, which has investors questioning if this is right time to ...
5hon MSN
Dr. Reddy's (NYSE:RDY) is scheduled to announce Q4 earnings results on Friday, May 9th, before market open. The consensus EPS ...
The long-running legal dispute between Amgen and Sanofi/Regeneron on two key patents covering the use of PCSK9 inhibitors to lower cholesterol has come to an end, with Sanofi emerging as the victor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results